Objective: Mycosis fungoides (MF) and Sézary syndrome (SS) represent the most frequently encountered subtypes of primary cutaneous T-cell lymphoma. The human leukocyte antigen (HLA) system was shown to be involved in susceptibility to MF/SS in various studies involving populations of different genetic backgrounds. We aimed to determine the possible association of HLA system with MF/SS in Turkish cases. Material and Methods: A total of 30 MF/SS cases underwent genotyping for HLA-A, HLA-B and HLA-DR loci. Samples from 30 healthy subjects were obtained as controls. Results: Statistically significant associations were found between MF and HLA-A31, HLA-B51 and HLA-DR3 alleles. A significantly higher frequency of HLA-B35 and HLADR4 was noted in healthy controls as compared with the patients. Conclusion: This study suggests that HLA genotypes are involved in susceptibility to MF. HLA-A31, HLA-B51 and HLA-DR3 alleles were considered as markers to disease susceptibility whereas HLA-B35 and HLA-DR4 alleles may be protective against neoplastic transformation.
Keywords: Disease susceptibility; HLA antigens; mycosis fungoides
Amaç: Mikozis fungoides (MF) ve Sézary sendromu (SS) primer T-hücreli deri lenfomalarının en sık rastlanan formlarıdır. Farklı genetik zeminlerden toplumlarda yapılan çeşitli çalışmalarda hastalığın gelişiminde sınıf I ve II insan lökosit antijenlerinin (HLA) rolü olabileceği gösterilmiştir. Çalışmanın amacı, Türk hastalarda mikozis fungoides ve Sézary sendromu ile HLA sisteminin muhtemel ilişkisinin araştırılmasıdır. Gereç ve Yöntemler:Mikozis fungoides ve Sézary sendromu tanısı olan 30 hastaya HLA-A, HLA-B ve HLA-DR lokuslarını değerlendirmek üzere genotipleme yapıldı. Sonuçlar 30 sağlıklı bireyin örnekleri ile karşılaştırıldı. Bulgular: HLA-A31, HLAB51 ve HLA-DR3 alelleri ile MF arasında istatistiksel olarak anlamlı ilişki saptandı. Hastalarla kıyaslandığında, kontrol grubunda HLA-B35 ve HLA-DR4 sıklığında anlamlı yükseklik mevcuttu. Sonuç: Çalışmamız HLA genotiplerinin MF'e yatkınlıkta rolü olabileceğini göstermektedir. HLAA31, HLA-B51 ve HLA-DR3 alelleri hastalığa yatkınlığı göstermekte iken HLA-B35 ve HLA-DR4 alelleri neoplastik dönüşümden koruyucu gibi gözükmektedir.
Anahtar Kelimeler: Hastalığa yatkınlık; HLA antijeni; mikozis fungoides
- Cerroni L. Past, present and future of cutaneous lymphomas. Semin Diagn Pathol. 2017;34(1):3-14. [Crossref] [PubMed]
- Foss FM, Girardi M. Mycosis fungoides and Sezary syndrome. Hematol Oncol Clin North Am. 2017;31(2):297-315. [Crossref] [PubMed]
- Bradford PT, Devesa SS, Anderson WF, Toro JR. Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Blood. 2009;113(21):5064-73. [Crossref] [PubMed] [PMC]
- Zinzani PL, Ferreri AJ, Cerroni L. Mycosis fungoides. Crit Rev Oncol Hematol. 2008;65(2):172-82. [Crossref] [PubMed]
- Beyer M, Möbs M, Humme D, Sterry W. Pathogenesis of Mycosis fungoides. J Dtsch Dermatol Ges. 2011;9(8):594-8. [Crossref] [PubMed]
- Duvic M, Edelson R. Cutaneous T-cell lymphoma. J Am Acad Dermatol. 2004;51(1 Suppl):S43-5. [Crossref] [PubMed]
- Howell WM, Carter V, Clark B. The HLA system: immunobiology, HLA typing, antibody screening and crossmatching techniques. J Clin Pathol. 2010;63(5):387-90. [Crossref] [PubMed]
- Brodsky FM, Lem L, Bresnahan PA. Antigen processing and presentation. Tissue Antigens. 1996;47(6):464-71. [Crossref] [PubMed]
- Howell WM. HLA and disease: guilt by asso ciation. Int J Immunogenet. 2014;41(1):1-12. [Crossref] [PubMed]
- Olsen E, Vonderheid E, Pimpinelli N, Willemze R, Kim Y, Knobler R, et al. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood. 2007;110(6):1713-22. [Crossref] [PubMed]
- Hodak E, Klein T, Gabay B, Ben-Amitai D, Bergman R, Gdalevich M, et al. Familial mycosis fungoides: report of 6 kindreds and a study of the HLA system. J Am Acad Dermatol. 2005;52(3 Pt 1):393-402. [Crossref] [PubMed]
- Vassallo C, Brazzelli V, Cestone E, Castello M, Ciocca O, Borroni RG, et al. Mycosis fungoides in childhood: description and study of two siblings. Acta Derm Venereol. 2007;87(6):529-32. [Crossref] [PubMed]
- MacKie R, Dick HM, de Sousa MB. Letter: HLA and mycosis fungoides. Lancet. 1976;1(7970):1179. [Crossref]
- Ryder LP, Anderson L, Svejgaard A. HLA and disease registry-third report. Tissue Antigens. 1979;15:1-60.
- Rosen ST, Radvany R, Roenigk H Jr, Terasaki PI, Bunn PA Jr. Human leukocyte antigens in cutaneous T cell lymphoma. J Am Acad Dermatol. 1985;12(3):531-4. [Crossref]
- Brazzelli V, Rivetti N, Badulli C, Carugno A, Grasso V, De Silvestri A, et al. Immunogenetic factors in mycosis fungoides: can the HLA system influence the susceptibility and prognosis of the disease? Long-term follow-up study of 46 patients. J Eur Acad Dermatol Venereol. 2014;28(12):1732-7. [Crossref] [PubMed]
- Safai B, Myskowski PL, Dupont B, Pollack MS. Association of HLA-DR5 with mycosis fungoides. J Invest Dermatol. 1983;80(5):395-7. [Crossref] [PubMed]
- Hodak E, Lapidoth M, Kohn K, David D, Brautbar B, Kfir K, et al. Mycosis fungoides: HLA class II associations among Ashkenazi and non-Ashkenazi Jewish patients. Br J Dermatol. 2001;145(6):974-80. [Crossref] [PubMed]
- Jackow CM, McHam JB, Friss A, Alvear J, Reveille JR, Duvic M. HLA-DR5 and DQB1*03 class II alleles are associated with cutaneous T-cell lymphoma. J Invest Dermatol. 1996;107(3):373-6. [Crossref] [PubMed]
- Reiter O, Ben Amitai D, Amitay-Laish I, Israeli M, Pavlovsky L, Hodak E. Pediatric mycosis fungoides: a study of the human leukocyte antigen system among Israeli Jewish patients. Arch Dermatol Res. 2017;309(10):851-6.[Crossref] [PubMed]
.: Process List